KTA
COCH icon

Keeley-Teton Advisors’s Envoy Medical COCH Stock Holding History

Keeley-Teton Advisors’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-40,217
Closed -$403K – 373
2022
Q4 		$403K Sell
40,217
-6,266
-13% -$62.3K 0.05% 308
2022
Q3 		$456K Sell
46,483
-1,170
-2% -$11.5K 0.06% 282
2022
Q2 		$467K Sell
47,653
-572
-1% -$5.6K 0.06% 295
2022
Q1 		$471K Sell
48,225
-288
-0.6% -$2.8K 0.05% 314
2021
Q4 		$473K Sell
48,513
-14
-0% -$137 0.05% 277
2021
Q3 		$471K Buy
48,527
+1,268
+3% +$12.3K 0.05% 279
2021
Q2 		$460K Buy
+47,259
New +$459K 0.05% 253

Other funds holding COCH

AMC
Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Keeley-Teton Advisors's COCH Position: Q1 2023 in Review

Keeley-Teton Advisors sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 40,217 shares — an estimated $403K sold.

Keeley-Teton Advisors first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $473K in Q4 2021. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • Keeley-Teton Advisors reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • Keeley-Teton Advisors sold 40,217 Envoy Medical shares in Q1 2023, an estimated $403K.
  • Keeley-Teton Advisors first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
  • Keeley-Teton Advisors's Envoy Medical position peaked at $473K in Q4 2021.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Keeley-Teton Advisors's 13F filing for Q1 2023, filed 10 May 2023.